Patent ID: 7232929

Claim:
A 2,2,3,3-tetramethylcyclopropane carboxamide derivative compound of formula I: including enantiomers, hydrates, solvates and pharmaceutically acceptable salts thereof wherein, R 1 is hydrogen or C 1 –C 6 alkyl group and R 2 is selected from the group consisting of: (a) a member having the structural formula: —C(═O)—(CH 2 ) n —NR 3 R 4 wherein n=0–6, R 3 and R 4 are the same or different and are independently selected from the group consisting of hydrogen, C 1 –C 6 alkyl group, an acyl group having the formula RC(═O)—, wherein R is a C 1 –C 6 alkyl group, and a keto group having the formula RC(═O)R′—, wherein R and R′ are C 1 –C 6 alkyl groups which may be the same or different; (b) a C 1 –C 6 alkyl sulfonamide group; (c) an (N—C 1 –C 6 alkyl)C 1 –C 6 alkyl sulfonamide group; (d) an aryl sulfonamide group; (e) a thiadiazole sulfonamide group; (f) a C 1 –C 6 alkyl-thiadiazole sulfonamide group; (g) an (N—C 1 –C 6 alkyl)aryl sulfonamide group; (h) an (N—C 1 –C 6 alkyl)C 1 –C 6 alkyl aryl sulfonamide group; (i) an (N—C 1 –C 6 alkyl)thiadiazole sulfonamide group; (j) an (N—C 1 –C 6 alkyl)C 1 –C 6 alkyl-thiadiazole sulfonamide group; and (k) a C 1 –C 6 alkoxy group.